Literature DB >> 21157967

Scavenger receptor BI: a multi-purpose player in cholesterol and steroid metabolism.

Menno Hoekstra1, Theo-Jc Van Berkel, Miranda Van Eck.   

Abstract

Scavenger receptor class B type I (SR-BI) is an important member of the scavenger receptor family of integral membrane glycoproteins. This review highlights studies in SR-BI knockout mice, which concern the role of SR-BI in cholesterol and steroid metabolism. SR-BI in hepatocytes is the sole molecule involved in selective uptake of cholesteryl esters from high-density lipoprotein (HDL). SR-BI plays a physiological role in binding and uptake of native apolipoprotein B (apoB)-containing lipoproteins by hepatocytes, which identifies SR-BI as a multi-purpose player in lipid uptake from the blood circulation into hepatocytes in mice. In adrenocortical cells, SR-BI mediates the selective uptake of HDL-cholesteryl esters, which is efficiently coupled to the synthesis of glucocorticoids (i.e. corticosterone). SR-BI knockout mice suffer from adrenal glucocorticoid insufficiency, which suggests that functional SR-BI protein is necessary for optimal adrenal steroidogenesis in mice. SR-BI in macrophages plays a dual role in cholesterol metabolism as it is able to take up cholesterol associated with HDL and apoB-containing lipoproteins and can possibly facilitate cholesterol efflux to HDL. Absence of SR-BI is associated with thrombocytopenia and altered thrombosis susceptibility, which suggests a novel role for SR-BI in regulating platelet number and function in mice. Transgenic expression of cholesteryl ester transfer protein in humanized SR-BI knockout mice normalizes hepatic delivery of HDL-cholesteryl esters. However, other pathologies associated with SR-BI deficiency, i.e. increased atherosclerosis susceptibility, adrenal glucocorticoid insufficiency, and impaired platelet function are not normalized, which suggests an important role for SR-BI in cholesterol and steroid metabolism in man. In conclusion, generation of SR-BI knockout mice has significantly contributed to our knowledge of the physiological role of SR-BI. Studies using these mice have identified SR-BI as a multi-purpose player in cholesterol and steroid metabolism because it has distinct roles in reverse cholesterol transport, adrenal steroidogenesis, and platelet function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21157967      PMCID: PMC3007109          DOI: 10.3748/wjg.v16.i47.5916

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  73 in total

1.  Increased oxidative stress in scavenger receptor BI knockout mice with dysfunctional HDL.

Authors:  Miranda Van Eck; Menno Hoekstra; Reeni B Hildebrand; Yuemang Yaong; Dominique Stengel; J Kar Kruijt; Wolfgang Sattler; Uwe J F Tietge; Ewa Ninio; Theo J C Van Berkel; Domenico Praticò
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-08-23       Impact factor: 8.311

2.  Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels.

Authors:  Ruud Out; Menno Hoekstra; Kim Habets; Illiana Meurs; Vivian de Waard; Reeni B Hildebrand; Yanan Wang; Giovanna Chimini; Johan Kuiper; Theo J C Van Berkel; Miranda Van Eck
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-11-15       Impact factor: 8.311

Review 3.  Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis.

Authors:  Miranda Van Eck; Marieke Pennings; Menno Hoekstra; Ruud Out; Theo Jc Van Berkel
Journal:  Curr Opin Lipidol       Date:  2005-06       Impact factor: 4.776

4.  The roles of different pathways in the release of cholesterol from macrophages.

Authors:  Maria Pia Adorni; Francesca Zimetti; Jeffrey T Billheimer; Nan Wang; Daniel J Rader; Michael C Phillips; George H Rothblat
Journal:  J Lipid Res       Date:  2007-08-29       Impact factor: 5.922

5.  Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI.

Authors:  Manojkumar Valiyaveettil; Niladri Kar; Mohammad Z Ashraf; Tatiana V Byzova; Maria Febbraio; Eugene A Podrez
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

6.  Absence of HDL cholesteryl ester uptake in mice via SR-BI impairs an adequate adrenal glucocorticoid-mediated stress response to fasting.

Authors:  Menno Hoekstra; Illiana Meurs; Mieke Koenders; Ruud Out; Reeni B Hildebrand; J Kar Kruijt; Miranda Van Eck; Theo J C Van Berkel
Journal:  J Lipid Res       Date:  2008-01-19       Impact factor: 5.922

7.  Scavenger receptor BI facilitates the metabolism of VLDL lipoproteins in vivo.

Authors:  Miranda Van Eck; Menno Hoekstra; Ruud Out; I Sophie T Bos; J Kar Kruijt; Reeni B Hildebrand; Theo J C Van Berkel
Journal:  J Lipid Res       Date:  2007-10-22       Impact factor: 5.922

8.  SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance.

Authors:  Lei Cai; Ailing Ji; Frederick C de Beer; Lisa R Tannock; Deneys R van der Westhuyzen
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

9.  The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity.

Authors:  Weifei Zhu; Sonika Saddar; Divya Seetharam; Ken L Chambliss; Christopher Longoria; David L Silver; Ivan S Yuhanna; Philip W Shaul; Chieko Mineo
Journal:  Circ Res       Date:  2008-01-03       Impact factor: 17.367

10.  Thrombocytopenia and platelet abnormalities in high-density lipoprotein receptor-deficient mice.

Authors:  Vandana S Dole; Jana Matuskova; Eliza Vasile; Ayce Yesilaltay; Wolfgang Bergmeier; Michael Bernimoulin; Denisa D Wagner; Monty Krieger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-04-24       Impact factor: 8.311

View more
  19 in total

1.  Reverse cholesterol transport revisited.

Authors:  Astrid-E van der Velde
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

2.  Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease.

Authors:  Paolo Zanoni; Sumeet A Khetarpal; Daniel B Larach; William F Hancock-Cerutti; John S Millar; Marina Cuchel; Stephanie DerOhannessian; Anatol Kontush; Praveen Surendran; Danish Saleheen; Stella Trompet; J Wouter Jukema; Anton De Craen; Panos Deloukas; Naveed Sattar; Ian Ford; Chris Packard; Abdullah al Shafi Majumder; Dewan S Alam; Emanuele Di Angelantonio; Goncalo Abecasis; Rajiv Chowdhury; Jeanette Erdmann; Børge G Nordestgaard; Sune F Nielsen; Anne Tybjærg-Hansen; Ruth Frikke Schmidt; Kari Kuulasmaa; Dajiang J Liu; Markus Perola; Stefan Blankenberg; Veikko Salomaa; Satu Männistö; Philippe Amouyel; Dominique Arveiler; Jean Ferrieres; Martina Müller-Nurasyid; Marco Ferrario; Frank Kee; Cristen J Willer; Nilesh Samani; Heribert Schunkert; Adam S Butterworth; Joanna M M Howson; Gina M Peloso; Nathan O Stitziel; John Danesh; Sekar Kathiresan; Daniel J Rader
Journal:  Science       Date:  2016-03-11       Impact factor: 47.728

3.  Antisense oligonucleotide inhibition of cholesteryl ester transfer protein enhances RCT in hyperlipidemic, CETP transgenic, LDLr-/- mice.

Authors:  Thomas A Bell; Mark J Graham; Richard G Lee; Adam E Mullick; Wuxia Fu; Dan Norris; Rosanne M Crooke
Journal:  J Lipid Res       Date:  2013-06-25       Impact factor: 5.922

4.  M2 macrophages exhibit higher sensitivity to oxLDL-induced lipotoxicity than other monocyte/macrophage subtypes.

Authors:  Suleiman A Isa; José S Ruffino; Maninder Ahluwalia; Andrew W Thomas; Keith Morris; Richard Webb
Journal:  Lipids Health Dis       Date:  2011-12-06       Impact factor: 3.876

5.  Acute stress show great influences on liver function and the expression of hepatic genes associated with lipid metabolism in rats.

Authors:  Xiaoling Gao; Yuaner Zeng; Shuqiang Liu; Shuling Wang
Journal:  Lipids Health Dis       Date:  2013-07-31       Impact factor: 3.876

6.  Clinically used selective estrogen receptor modulators affect different steps of macrophage-specific reverse cholesterol transport.

Authors:  María E Fernández-Suárez; Joan C Escolà-Gil; Oscar Pastor; Alberto Dávalos; Francisco Blanco-Vaca; Miguel A Lasunción; Javier Martínez-Botas; Diego Gómez-Coronado
Journal:  Sci Rep       Date:  2016-09-07       Impact factor: 4.379

Review 7.  Primary genetic disorders affecting high density lipoprotein (HDL).

Authors:  Constantine E Kosmas; Delia Silverio; Andreas Sourlas; Frank Garcia; Peter D Montan; Eliscer Guzman
Journal:  Drugs Context       Date:  2018-09-11

8.  Cholesterol trafficking and raft-like membrane domain composition mediate scavenger receptor class B type 1-dependent lipid sensing in intestinal epithelial cells.

Authors:  Etienne Morel; Sara Ghezzal; Géraldine Lucchi; Caroline Truntzer; Jean-Paul Pais de Barros; Françoise Simon-Plas; Sylvie Demignot; Chieko Mineo; Philip W Shaul; Armelle Leturque; Monique Rousset; Véronique Carrière
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-12-02       Impact factor: 5.228

9.  Combined effect of Cameo2 and CBP on the cellular uptake of lutein in the silkworm, Bombyx mori.

Authors:  Wei Wang; Mao-Hua Huang; Xiao-Long Dong; Chun-Li Chai; Cai-Xia Pan; Hui Tang; Yan-Hong Chen; Fang-Yin Dai; Min-Hui Pan; Cheng Lu
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

10.  Animal models of coronary heart disease.

Authors:  Jiawei Liao; Wei Huang; George Liu
Journal:  J Biomed Res       Date:  2015-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.